Purchases and Sales Made in Q2 2021 in Ars Pharmaceuticals, Inc. Comm (SPRY)
This table provides information about the institutional ownership of Ars Pharmaceuticals, Inc. Comm (SPRY) during Q2 2021. The information is specifically focused on institutions that hold shares of ARS PHARMACEUTICALS, INC. COMM.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
SELL
|
- |
-3.36K- 95.06% |
N/A
|
175
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-3.79K- 86.58% |
N/A
|
588
$0
|
|
|
Aug 11, 2021
Q2 2021
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-4.59K- 37.21% |
N/A
|
7.74K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-5.35KClosed |
N/A
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-8.69K- 6.45% |
N/A
|
126K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Zimmer Partners, LP
New York, NY |
SELL
|
- |
-10KClosed |
N/A
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Caas Capital Management LP
New York, NY |
SELL
|
- |
-25KClosed |
N/A
|
0
$0
|
|
|
Jul 23, 2021
Q2 2021
|
Bank Julius Baer & Co. Ltd, Zurich
|
SELL
|
- |
-28.2KClosed |
N/A
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-66K- 67.81% |
N/A
|
31.3K
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-85KClosed |
N/A
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-94.6K- 32.89% |
N/A
|
193K
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-125KClosed |
N/A
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-261K- 52.18% |
N/A
|
239K
$0
|